Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Acad Pediatr. 2021 May-Jun;21(4 Suppl):S57–S64. doi: 10.1016/j.acap.2020.11.008

Table 1.

4:3:1:3:3:1:4 Vaccine Series* Coverage for Children 19 to 35 Months of Age by Participation Policy Type

IIS Participation Policy Type No. of Jurisdictions 4:3:1:3:3:1:4 Vaccine Series Coverage For 19–35 Months of Age (%) Median 4:3:1:3:3:1:4 Vaccine Series Coverage For 19–35 Months of Age (%)
Mandatory participation with no opt out option 12 18–88 67
Mandatory participation with opt out option 2 46, 70 58
Implicit consent to participate with opt out option 45 9–77 62
Opt in participation only 4 41–75 56
N/A— No IIS 1

IIS indicates immunization information systems.

*

4:3:1:3:3:1:4 vaccine series refers to: 4 doses of Diphtheria, Tetanus, and Pertussis (DtaP), ≥3 doses of poliovirus vaccine, ≥1 dose of measles-containing vaccine, the full series of Haemophilus influenzae type b vaccine (Hib–≥3 or ≥4 doses, depending on product type), ≥3 doses of Hepatitis B (HepB) vaccine, ≥1 dose of varicella vaccine, and ≥4 doses of Pneumococcal (PCV) vaccine.